Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Classification of Systems-I01:26

Classification of Systems-I

Linearity is a system property characterized by a direct input-output relationship, combining homogeneity and additivity.
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional principal component analysis forsparse censored data.

Biometrika·2026
Same author

Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trial.

Biometrics·2026
Same author

Empirical Bound Information-Directed Sampling for Norm-Agnostic Bandits.

Reinforcement learning journal·2026
Same author

Assessing the utility of the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors.

Cancer·2026
Same author

mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART).

Epilepsia·2026
Same author

Independent Increments and Group Sequential Tests.

Statistics in medicine·2025
Same journal

Power and sample size calculation of two-sample projection-based testing for sparsely observed functional data.

Stat·2026
Same journal

Bias correction for nonignorable missing counts of areal HIV new diagnosis.

Stat·2025
Same journal

Reaping what you SOW: Guidelines and strategies for writing scopes of work for statistical consulting.

Stat·2025
Same journal

Communication-Efficient Distributed Estimation of Causal Effects With High-Dimensional Data.

Stat·2025
Same journal

Multiple third-variable analysis for competing risk data-With an application to explore racial disparity in breast cancer recurrence.

Stat·2025
Same journal

Reproducible research practices: A tool for effective and efficient leadership in collaborative statistics.

Stat·2024
See all related articles

Related Experiment Video

Updated: May 11, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Estimating Optimal Treatment Regimes from a Classification Perspective.

Baqun Zhang1, Anastasios A Tsiatis, Marie Davidian

  • 1Department of Preventive Medicine, Northwestern University, Chicago, 60611, U.S.A.

Stat
|May 7, 2013
PubMed
Summary
This summary is machine-generated.

Researchers developed a new framework to identify optimal treatment regimes using patient data. This approach transforms treatment regime estimation into a classification problem, enabling broader use of machine learning algorithms for personalized medicine.

Keywords:
classificationdoubly robust estimatorinverse probability weightingpersonalized medicinepotential outcomespropensity score

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Related Experiment Videos

Last Updated: May 11, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Area of Science:

  • Biostatistics
  • Machine Learning
  • Clinical Data Analysis

Background:

  • Increasingly large and complex patient-level datasets necessitate advanced methods for treatment regime estimation.
  • Existing methods for optimal treatment regime estimation have limitations in flexibility and applicability to diverse data types.

Purpose of the Study:

  • To introduce a novel, general framework for estimating optimal treatment regimes.
  • To unify existing estimation methods and incorporate advanced classification algorithms.

Main Methods:

  • The proposed framework reframes optimal treatment regime estimation as a classification problem.
  • Any classification method compatible with case weights can be utilized within this framework.
  • The approach was validated using data from a breast cancer clinical trial.

Main Results:

  • Common parametric, semi-parametric, and robust regression estimators are shown to be special cases of the proposed framework.
  • The framework facilitates the application of a wide range of machine learning classification algorithms for treatment regime estimation.
  • Demonstrated utility in a real-world clinical trial setting.

Conclusions:

  • The novel classification-based framework offers a flexible and powerful approach to estimating optimal treatment regimes.
  • This methodology expands the toolkit for personalized medicine by integrating advanced machine learning techniques.
  • The approach is applicable to both observational studies and randomized clinical trials.